Key Players
Fiercely competitive, the Apheresis market appears to be fragmented due to many large and small players churning the competition in the market. These players try to gain an edge over their competitors by adopting strategies such as partnership, acquisition, expansion, collaboration, and product & technology launch.
Key players leading the global Apheresis market include Fresenius Medical Care (Germany), Asahi Kasei Medical Co. Ltd. (Japan), Terumo BCT, Inc. (US), Kawasumi Laboratories Inc. (Japan), Haemonetics Corporation (US), HemaCare Corporation (US), Nikkiso Co., Ltd. (Japan), Kaneka Corporation (Japan), Cerus Corporation (US), Therakos, Inc. (US), and B. Braun Melsungen AG (Germany) among others.
Market Sketch
The Global Apheresis Market is growing pervasively majorly due to the development in the new apheresis techniques and the increasing prevalence of different chronic diseases. The growing demand for the Apheresis products such as human-derived biological products to be used in the biomedical research, drug discovery, and the development of cellular therapy process is a dominant driving force that is escalating the market on the global platform.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1508
Acknowledging the exponential traction, the market perceives currently Market Research Future (MRFR), in its recently published study report asserts that the global Apheresis market will register approximately 10.2% CAGR from 2017 to 2023, garnering exponential accruals by 2023. Great strides transpired in the biotechnology and advancements in Apheresis machines and devices led by the substantial investments made into R&D activities are in turn, paying off well increasing the size of the market.
Additionally, factors such as the ever-increasing population that is inclining towards sedentary lifestyle, and urbanization support the market growth, increasing the occurrences of chronic diseases and disorders. Improving economic conditions, worldwide, substantiate market growth, availing access to excellent healthcare and rising per capita healthcare expenditures.
On the flip side, factors such as the high costs of Apheresis products and lack of external funding especially in the underdeveloped regions are impeding the growth of the market in these areas. Besides, the unmet clinical needs alongside the lack of expertise and the gap in demand and supply of the patient-donor material when sourcing human starting material are some of the factors challenging the industry currently.
Industry Related News
March 28, 2019 – HemaCare Corporation (the US), a leading player involved in the customization of human-derived biological products & services announced its partnership with Tissue Solutions Ltd. (the US), a leading global provider of diseased human bio-samples for research to supply customers with a wide range of well-qualified disease-state biomaterials in fresh, frozen, and FFPE formats.
Researchers and pharmaceutical companies often face the challenges of getting access to patient-donor material when sourcing human starting material. As a therapy or drug moves through research and development to commercialization, the need for donor samples that meet specific disease criteria increases as it offers the closest approximation of real-life cellular responses.
Hence, the duo companies had planned to advance discoveries by providing scientists with high-quality disease-state biospecimens to support preclinical and clinical research. This partnership will allow HemaCare to further meet growing market needs by expanding its current disease-state product portfolio gaining access to Tissue Solutions’ pathology-verified frozen and FFPE tissues and hard-to-source disease samples including tumor tissues and dissociated tumor cells isolated from freshly resected tumors.
Industry Updates
January 2018: MedAware Systems Inc. has recently launched a comprehensive database on apheresis through its SOHInfo division, carrying data from clinical trials, medical journals, cohort studies, and others.
Segments
For ease of understanding, the market is segmented into six key dynamics: –
By Products : Devices and Disposables.
By Procedures : Leukapheresis, Plateletpheresis, Erythrocytapheresis, and Plasmapheresis among others.
By Methods : Centrifugation and Filtration.
By Application : Renal Diseases, Oncological Diseases, Cardiovascular Diseases, Neurological Diseases, Haematological Diseases, and Immunological Diseases among others.
By End-users : Blood Banks and Hospitals among others.
By Regions : North America, Asia Pacific, Europe, and the Rest-of-the-World.
Regional Analysis
Heading with its well-developed healthcare sector, the North American region is expected to retain its dominance over the global Apheresis market. Also, factors such as the availability of funds for R&D activities for the development of new therapeutics, and treatment impact the growth of the market, positively. Besides, the presence of a large number of players alongside the well-defined per capita healthcare expenditure acts as a major tailwind, driving the growth of the regional market.
Furthermore, factors such as the continuous technological advancements and increasing opportunities for apheresis products that are led by the growing number of patients suffering from chronic diseases are spurring the growth of the regional market. The US, backed by an increasing number of care facilities offering cell therapies alongside the advanced devices, majorly contribute to the growth of the regional market.
The European Apheresis market backed by the presence of well-established players and investments transpired into R&D activities, stands at the second largest position, globally. Furthermore, initiatives undertaken by private and public organizations to spread awareness towards keeping good health are impacting the market growth positively.
The Apheresis market in the Asia Pacific region is rapidly emerging as a lucrative market, globally. Factors substantiating the regional market include increasing healthcare expenditures and favorable government policies mainly in India and China.
Furthermore, factors like the increasing demand for different blood components for the patients, rapid development in healthcare, and rising healthcare expenditure are supporting the growth of the regional market. Additionally, government support and substantial investment transpired into R&D activities alongside the rapidly developing healthcare infrastructure and huge patient population are augmenting the demand for Apheresis products in the region.
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
TOC Continued…
Browse Complete Report @ https://www.marketresearchfuture.com/reports/apheresis-market-1508
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/apheresis-market-1508